These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24485894)

  • 1. Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.
    Downey LA; Loftis JM
    Eur J Pharmacol; 2014 Mar; 727():125-9. PubMed ID: 24485894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychostimulant use and the brain.
    Lappin JM; Sara GE
    Addiction; 2019 Nov; 114(11):2065-2077. PubMed ID: 31321819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.
    Dalley JW; Lääne K; Theobald DE; Peña Y; Bruce CC; Huszar AC; Wojcieszek M; Everitt BJ; Robbins TW
    Neuropsychopharmacology; 2007 May; 32(5):1195-206. PubMed ID: 17035931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
    Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
    Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
    Sharma HS; Sjöquist PO; Ali SF
    Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction.
    Robledo P
    Curr Drug Targets; 2010 Apr; 11(4):429-39. PubMed ID: 20017726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.
    Chang L; Alicata D; Ernst T; Volkow N
    Addiction; 2007 Apr; 102 Suppl 1():16-32. PubMed ID: 17493050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.
    Wang LJ; Chen MY; Lin CY; Chong MY; Chou WJ; You YH; Tsai CP; Chen YS; Lu SF
    Subst Abuse Treat Prev Policy; 2018 Dec; 13(1):50. PubMed ID: 30577882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated persistent acute global amnesia after acute abuse of 3,4-methylenedioxy-methamphetamine (MDMA).
    Hauw F; Meppiel E; Steichen O; Conan PL; Capron J; de Broucker T
    J Neurol Sci; 2018 Mar; 386():36-38. PubMed ID: 29406963
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.
    Moratalla R; Khairnar A; Simola N; Granado N; García-Montes JR; Porceddu PF; Tizabi Y; Costa G; Morelli M
    Prog Neurobiol; 2017 Aug; 155():149-170. PubMed ID: 26455459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies.
    Karimi-Haghighi S; Mahmoudi M; Sayehmiri F; Mozafari R; Haghparast A
    Eur J Pharmacol; 2023 Jul; 951():175669. PubMed ID: 36965745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use.
    Todd G; Burns L; Pearson-Dennett V; Esterman A; Faulkner PL; Wilcox RA; Thewlis D; Vogel AP; White JM
    Drug Alcohol Depend; 2019 Dec; 205():107595. PubMed ID: 31600615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
    Brière FN; Fallu JS; Janosz M; Pagani LS
    J Epidemiol Community Health; 2012 Nov; 66(11):990-4. PubMed ID: 22516739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin attenuates depressive-like behaviour of methamphetamine withdrawal in mice: A mechanistic approach.
    Hosseini MJ; Arabiyan A; Mobassem S; Ghavimi H
    World J Biol Psychiatry; 2023 Mar; 24(3):209-222. PubMed ID: 35673936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice.
    Ru Q; Xiong Q; Zhou M; Chen L; Tian X; Xiao H; Li C; Li Y
    Psychiatry Res; 2019 Jan; 271():476-483. PubMed ID: 30544074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine abuse and "meth mouth".
    Rhodus NL; Little JW
    Northwest Dent; 2005; 84(5):29, 31, 33-7. PubMed ID: 16317979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
    Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
    Neurosci Lett; 2002 Sep; 330(3):280-4. PubMed ID: 12270646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and antinociceptive effects of different psychostimulant drugs in prenatally methamphetamine-exposed rats.
    Yamamotová A; Šlamberová R
    Physiol Res; 2012; 61(Suppl 2):S139-47. PubMed ID: 23130899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.
    Jing L; Li JX
    Eur J Pharmacol; 2015 Aug; 761():345-52. PubMed ID: 26092759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.